Lidocaine Hcl Injection, Solution
Product Images NDC 51662-1538

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lidocaine Hcl (NDC 51662-1538). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Vial Labeling (51662 1538 1 Serialized Vial Labeling)

Serialized Vial Labeling (51662 1538 1 Serialized Vial Labeling)
This is a package of Lidocaine HCl injection with a strength of 300mg/30mL. The package insert should be referred to for more information. It is distributed by HF Acquisition Co., LLC and manufactured by Hospira, Inc. It is a prescription-only medication and the National Drug Code is 0409-4279-16. It is preservative-free. The product code is 13351DK and the lot number is RL-7435.*
FDA Label Image

Dosage 1 (D And A 1)

Dosage 1 (D And A 1)
This is a list of various concentrations and volumes of single-dose containers, including 1%, 1.5%, and 2% concentrations of an unknown substance. The containers are either 30 mL teartop vials or 20 mL and 10 mL ampuls. No further information is provided.*
FDA Label Image

Dosage 2 (D And A 2)

Dosage 2 (D And A 2)
The text is a table showing the recommended dosages of Lidocaine Hydrochloride Injection, USP for different medical procedures such as infiltration, peripheral nerve blocks, obstetrical analgesia and surgical anesthesia. The table specifies the concentration, volume, total dose, and dose determined by the number of dermatomes to be anesthetized.*
FDA Label Image

Structure (Description Structure)

FDA Label Image

Description Table (Description Table)

Description Table (Description Table)
This is a table showing the concentration of lidocaine HCl (anhydrous) and sodium chloride at different levels, measured in mg/mL. The concentrations of lidocaine HCl are listed as 10, 15, and 20 mg/mL, while the concentration of sodium chloride is listed as 6.5 mg/mL.*
FDA Label Image

How Supplied (How Supplied)

FDA Label Image
FDA Label Image

Precautions (Precautions Table)

Precautions (Precautions Table)
This text provides a list of drugs that are associated with methemoglobinemia, a condition in which the blood is unable to carry oxygen effectively. Examples of such drugs include nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs such as acetaminophen, metoclopramide, quinine, and sulfasalazine.*
FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)
This is a description of Lidocaine HCI, a single-dose, preservative-free medication used for infiltration and nerve block procedures, including epidural and caudal. It contains lidocaine HCl, anhyd. 10 mg, NaCl 7 mg, and may contain HCI and/or NaOH for pH adjustment. The pH is adjusted to 5.0 to 7.0. It is sterile and non-pyrogenic with a dosage that can be found in the insert. It should be discarded if any of it is unused. The medication has a controlled room temperature and is distributed by Hospira, Inc., Lake Forest, USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.